Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60,026,563
-
Total 13F shares
-
36,272,402
-
Share change
-
-3,290,088
-
Total reported value
-
$145,130,796
-
Put/Call ratio
-
42%
-
Price per share
-
$4.00
-
Number of holders
-
110
-
Value change
-
-$44,887,818
-
Number of buys
-
53
-
Number of sells
-
55
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2021
As of 31 Dec 2021,
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,272,402 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, EAGLE ASSET MANAGEMENT INC, Verition Fund Management LLC, Prosight Management, LP, GEODE CAPITAL MANAGEMENT, LLC, and Woodline Partners LP.
This page lists
110
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.